Nordimet (methotrexate) / Nordic Group - LARVOL DELTA

Alfasigma to acquire Nordic Group B.V. expanding its specialty care portfolio and presence in Europe (Alfasigma Press Release) - "The acquisition will add Nordic Pharma’s established rheumatoid arthritis business, led by the Nordimet methotrexate franchise, to Alfasigma’s rheumatology portfolio...It will also deepen Alfasigma’s commercial reach through direct operations in 18 countries across Europe and add commercial platforms in Canada and Japan. In addition to rheumatology, the acquisition includes Nordic Pharma’s portfolio in women’s health, critical care and ophthalmology."

M&A • Immunology • Rheumatoid Arthritis